Product Information

FEBUXOSTAT 80 MG TABLET is a generic product labeled by Viona Pharmaceuticals Inc., priced at $0.2810 per EA under NDC 72578013706. Its NADAC has been published 151 times since Oct 4, 2023.

FDA first approved this application on Jan 9, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

FEBUXOSTAT 80 MG TABLET

febuxostat
$0.2810per EA

Strength

80 mg/1

NDC

72578013706

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

FEBUXOSTAT

Approval Type

Generic (ANDA)

FDA Application

ANDA205443

FDA Approved

1/9/2023

TE Code

AB

On Market Since

3/31/2023

Pharmacological Classes

Xanthine Oxidase Inhibitor
Xanthine Oxidase Inhibitors

Price Statistics

The NADAC for FEBUXOSTAT 80 MG TABLET has been published 151 times since Oct 4, 2023, and over the history we have for it it has declined 55.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2810 per EA
All-time high$0.6539 (Dec 13, 2023)
All-time low$0.2636 (Feb 18, 2026)
52-week high$0.4210
52-week low$0.2636
Median price$0.4609
Average price$0.4409
Largest weekly change+30.2% (Aug 21, 2024)
Weeks tracked151
Tracking sinceOct 4, 2023

Price History

1W

-11.0%

1M

-11.0%

3M

-20.5%

6M

+6.6%

1Y

-33.3%

3Y

N/A

5Y

N/A

All

-55.3%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of FEBUXOSTAT 80 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for FEBUXOSTAT 80 MG TABLET, manufactured by Viona Pharmaceuticals Inc., is $0.2810 per EA (NDC 72578013706), effective Aug 19, 2026.

How has the price of FEBUXOSTAT 80 MG TABLET changed over time?

Over the history we have for it, the NADAC for FEBUXOSTAT 80 MG TABLET has declined 55.3%. It has been tracked across 151 weekly CMS publications since Oct 4, 2023.

What are the highest and lowest recorded NADAC prices for FEBUXOSTAT 80 MG TABLET?

Since Oct 4, 2023, the NADAC for FEBUXOSTAT 80 MG TABLET has ranged from a low of $0.2636 (Feb 18, 2026) to a high of $0.6539 (Dec 13, 2023), with a median of $0.4609 per EA.

Are there cheaper alternatives to FEBUXOSTAT 80 MG TABLET?

5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FEBUXOSTAT 80 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures FEBUXOSTAT 80 MG TABLET?

FEBUXOSTAT 80 MG TABLET (NDC 72578013706) is labeled by Viona Pharmaceuticals Inc., and CMS classifies it as a generic product.